Health Canada, a department of the Government of Canada, regulates therapeutic drugs in Canada through a rigorous licensing process, which includes an extensive pre-market review and the ongoing post-market assessment of a drug's safety, effectiveness and quality. As part of this process, Heath Canada conducts risk/benefit assessments, monitors adverse reactions, and communicates information about risks to health professionals and the public.
- All drugs approved for sale in Canada have an eight-digit Drug Identification Number (DIN) - this is the Canadian equivalent of the U.S. NDC number. The DIN assures you that Health Canada has assessed a drug, and considers it safe and effective when used as directed on the label. The DIN also provides a way to track adverse drug reactions.
- Health Canada licenses and conducts regular inspections of companies that manufacture, import and/or distribute drugs. In addition, Health Canada investigates complaints related to the sale or use of therapeutic drugs, including complaints about Web sites that sell drugs, and takes action where appropriate.
For more information on drug safety, please visit the Health Canada home page.
- Rx International's exclusive pharmacy is audited regularly by the College of Pharmacists of British Columbia to ensure full compliance with the College's extensive Standards of Practice.
Please click here for more information on our prescription drug dispensing standards.